A tailored approach to horizon scanning for cancer medicines
Horizon scanning (HS) is the systematic identification of emerging therapies to inform policy and decision-makers. We developed an agile and tailored …
Horizon scanning (HS) is the systematic identification of emerging therapies to inform policy and decision-makers. We developed an agile and tailored …
In 2023, the Common Sense Oncology (CSO) movement was launched with the goal of recalibrating cancer care to focus on outcomes that matter to patients.…
Available online 5 March 2024, 101344 Author links open overlay panel Ziad A. Ali MD, DPhil a, Antonio Dager MD b, Mauricio Zúñiga MD b,…
Little is known about the effect tubulointerstitial nephropathies have in modulating maternal-fetal outcomes in pregnancy. Therefore, we analyzed the …
Available online 21 August 2023, 101121 Author links open overlay panel Rajesh V. Swaminathan MD, FSCAI (Vice-Chair) a, Cara Anne East MD b, Dmitriy N.…
“AEACaP” Asociación Española de Afectados de Cáncer de Pulmón.Séptimo capítulo del Proyecto A Pulmón en el que ascendemos al techo de Euskadi: Aizkorri (1.52…
Register for this complimentary event with the “Register Now” button above, which will take you to our Zoom registration page. Join us on Wednesday, May…
Percutaneous revascularization is the primary strategy for treating lower extremity venous and arterial disease. Angiography is limited by its ability…
Delirium is a potentially severe form of acute encephalopathy. Minocycline has neuroprotective effects in animal models of neurological diseases; howe…
The prevalence of calcification in obstructive coronary artery disease is on the rise. Percutaneous coronary intervention of these calcified lesions i…
In 2023, the Common Sense Oncology (CSO) movement was launched with the goal of recalibrating cancer care to focus on outcomes that matter to patients.…